These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 11268642)

  • 1. [Mastoparan as a G protein activator].
    Mukai H; Wakamatsu K
    Tanpakushitsu Kakusan Koso; 2001 Mar; 46(4 Suppl):423-8. PubMed ID: 11268642
    [No Abstract]   [Full Text] [Related]  

  • 2. The Rac/Cdc42 guanine nucleotide exchange factor beta1Pix enhances mastoparan-activated Gi-dependent pathway in mast cells.
    Chahdi A; Sorokin A; Dunn MJ; Landry Y
    Biochem Biophys Res Commun; 2004 Apr; 317(2):384-9. PubMed ID: 15063769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic profiling of the molecular targets of interactions of the mastoparan peptide Protopolybia MP-III at the level of endosomal membranes from rat mast cells.
    dos Santos LD; Aparecido dos Santos Pinto JR; Menegasso AR; Saidemberg DM; Caviquioli Garcia AM; Palma MS
    Proteomics; 2012 Aug; 12(17):2682-93. PubMed ID: 22761183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of CD47 receptors causes histamine secretion from mast cells.
    Sick E; Niederhoffer N; Takeda K; Landry Y; Gies JP
    Cell Mol Life Sci; 2009 Apr; 66(7):1271-82. PubMed ID: 19205621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cryptide signaling: Amphiphilic peptide-induced exocytotic mechanisms in mast cells.
    Mukai H; Kikuchi M; Fukuhara S; Kiso Y; Munekata E
    Biochem Biophys Res Commun; 2008 Oct; 375(1):22-6. PubMed ID: 18657517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mastoparan analog without lytic effects and its stimulatory mechanisms in mast cells.
    Mukai H; Kikuchi M; Suzuki Y; Munekata E
    Biochem Biophys Res Commun; 2007 Oct; 362(1):51-55. PubMed ID: 17692824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of ganglioside on mastoparan-induced cytotoxicity and degranulation in lipid raft of connective tissue type mast cell.
    Nishikawa H; Kitani S
    J Biochem Mol Toxicol; 2011; 25(3):158-68. PubMed ID: 21671308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. G protein activation: a receptor-independent mode of action for cationic amphiphilic neuropeptides and venom peptides.
    Mousli M; Bueb JL; Bronner C; Rouot B; Landry Y
    Trends Pharmacol Sci; 1990 Sep; 11(9):358-62. PubMed ID: 2122563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms for the effect of mastoparan on G proteins in tissues of vertebrates and invertebrates.
    Shpakov AO; Pertseva MN
    Bull Exp Biol Med; 2006 Mar; 141(3):302-6. PubMed ID: 17073145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elucidation of structural requirements of mastoparan for mast cell activation-toward the comprehensive prediction of cryptides acting on mast cells.
    Mukai H; Suzuki Y; Kiso Y; Munekata E
    Protein Pept Lett; 2008; 15(9):931-7. PubMed ID: 18991769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Polycationic peptides as nonhormonal regulators of chemosignal systems].
    Shpakov AO
    Zh Evol Biokhim Fiziol; 2009; 45(4):355-67. PubMed ID: 19764631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative study of molecular mechanisms of natural and synthetic polycationic peptides action on the activity of the adenylyl cyclase signaling system].
    Shpakov AO; Gur'ianov IA; Kuznetsova LA; Plesneva SA; Zakharova ET; Vlasov GP; Pertseva MN
    Tsitologiia; 2006; 48(5):450-9. PubMed ID: 16892855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GTP-binding protein-independent potentiation by mastoparan of IL-1beta-induced nitric oxide release from insulin-secreting HIT-T15 cells.
    Chen HQ; Veluthakal R; Palanivel R; Kowluru A
    Apoptosis; 2004 Mar; 9(2):145-8. PubMed ID: 15004511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. rab3-peptide stimulates exocytosis from mast cells via a pertussis toxin-sensitive mechanism.
    Law GJ; Northrop AJ; Mason WT
    FEBS Lett; 1993 Oct; 333(1-2):56-60. PubMed ID: 8224171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mastoparan inhibits beta-adrenoceptor-G(s) signaling by changing the localization of Galpha(s) in lipid rafts.
    Sugama J; Yu JZ; Rasenick MM; Nakahata N
    Cell Signal; 2007 Nov; 19(11):2247-54. PubMed ID: 17692506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular delivery of bioactive peptides to RBL-2H3 cells induces beta-hexosaminidase secretion and phospholipase D activation.
    Howl J; Jones S; Farquhar M
    Chembiochem; 2003 Dec; 4(12):1312-6. PubMed ID: 14661273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agmatine: a mastoparan-like activity related to direct activation of heterotrimeric G proteins.
    Ferry X; Landry Y
    Eur J Pharmacol; 2002 Jan; 435(1):19-26. PubMed ID: 11790374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial peptides from the venoms of Vespa bicolor Fabricius.
    Chen W; Yang X; Yang X; Zhai L; Lu Z; Liu J; Yu H
    Peptides; 2008 Nov; 29(11):1887-92. PubMed ID: 18723059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chimerism: a strategy to expand the utility and applications of peptides.
    Howl J
    Methods Mol Biol; 2005; 298():25-41. PubMed ID: 16044538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unexpected contractile response from the G-protein activator mastoparan in cardiac myocytes.
    Van Meel JC; Haigh RM
    Eur J Pharmacol; 1993 Nov; 247(3):357-8. PubMed ID: 8307108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.